BioSig Technologies ROE 2024

BioSig Technologies Aktienanalyse

What does BioSig Technologies do?

Biosig Technologies Inc is a medical technology company based in New York, specializing in the development of advanced electrophysiological (EP) instruments and accessories for use in hospitals and clinics. The company was founded in 2009 and successfully went public in June 2018. The main task of Biosig Technologies is to provide doctors and medical professionals with helpful instruments that simplify the difficult work of EP tests and ablations. The development of EP instruments typically requires high specialization, as knowledge of both electrophysiology and engineering is required. However, Biosig has already gained a high level of expertise in this field and has established itself as a leading company in the industry. Biosig Technologies' business model is based on selling EP instruments and accessories to hospitals and clinics in the US and international markets. The products include the "PURE EP System," an electrophysiological signal processing and recording system specifically designed for use in EP tests and ablations. The "PURE EP System" allows doctors to obtain accurate information about the electrical activity of the heart in order to improve the diagnosis and treatment of cardiac arrhythmias. The "PURE EP System" has proven its excellence in practice and is successfully used by many clinics and hospitals in the US. The system offers higher sensitivity and accuracy than conventional electrophysiological instruments, enabling better differentiation and representation of signals originating from different heart tissues. This allows doctors to make more accurate diagnoses and develop more targeted treatment strategies. Biosig Technologies offers a wide range of products and services tailored to the needs of customers in various areas of healthcare. The company also provides excellent customer support and training to ensure that users properly utilize the instruments and maximize their benefits. In addition to the EP field, the company is also exploring the use of the technology in other areas of medicine. Biosig Technologies actively works on the development of instruments to improve respiratory monitoring and facilitate the use of robots in surgery. The company plans to bring more instruments and accessories to the market in the future to expand its portfolio and meet additional customer needs. Biosig Technologies is a dynamic company with a high degree of innovation and a strong focus on the needs of doctors and medical professionals. The company aims to improve healthcare by providing advanced instruments and accessories, making a positive contribution to society. BioSig Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding BioSig Technologies's Return on Equity (ROE)

BioSig Technologies's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing BioSig Technologies's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

BioSig Technologies's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in BioSig Technologies’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about BioSig Technologies stock

What is the ROE (Return on Equity) of BioSig Technologies this year?

The ROE of BioSig Technologies this year is 9.97 undefined.

How has the Return on Equity (ROE) of BioSig Technologies developed compared to the previous year?

The ROE of BioSig Technologies has increased by -115.29% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of BioSig Technologies?

A high ROE indicates that BioSig Technologies generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of BioSig Technologies?

A low ROE can indicate that BioSig Technologies is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of BioSig Technologies affect the company?

A change in ROE (Return on Equity) of BioSig Technologies can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of BioSig Technologies?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of BioSig Technologies?

Some factors that can influence BioSig Technologies's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does BioSig Technologies pay?

Over the past 12 months, BioSig Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioSig Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of BioSig Technologies?

The current dividend yield of BioSig Technologies is .

When does BioSig Technologies pay dividends?

BioSig Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioSig Technologies?

BioSig Technologies paid dividends every year for the past 0 years.

What is the dividend of BioSig Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioSig Technologies located?

BioSig Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioSig Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioSig Technologies from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did BioSig Technologies pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of BioSig Technologies in the year 2023?

In the year 2023, BioSig Technologies distributed 0 USD as dividends.

In which currency does BioSig Technologies pay out the dividend?

The dividends of BioSig Technologies are distributed in USD.